Abstract
Sarcopenia, frailty, and malnutrition are prevalent complications in patients with end-stage liver disease (ESLD) and are associated with increased risk of morbidity and mortality. It is valuable to measure nutritional status, sarcopenia, and frailty over time in order to create interventions tailored to individuals with ESLD. Evaluating sarcopenia and frailty in patients with ESLD is challenging. Further work is needed to perfect these assessments so that clinicians can incorporate these assessments into their decision-making and management plans for cirrhotic patients.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 589-605 |
| Number of pages | 17 |
| Journal | Clinics in liver disease |
| Volume | 23 |
| Issue number | 4 |
| DOIs | |
| State | Published - Nov 2019 |
Bibliographical note
Publisher Copyright:© 2019 Elsevier Inc.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 2 Zero Hunger
Keywords
- Frailty
- Liver transplantation/hepatology
- Malnutrition
- Rehabilitation
- Sarcopenia
Fingerprint
Dive into the research topics of 'Frailty, Sarcopenia, and Malnutrition in Cirrhotic Patients'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS